BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36243664)

  • 1. How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis.
    Siltari A; Lönnerbro R; Pang K; Shiranov K; Asiimwe A; Evans-Axelsson S; Franks B; Kiran A; Murtola TJ; Schalken J; Steinbeisser C; Bjartell A; Auvinen A;
    Clin Genitourin Cancer; 2023 Apr; 21(2):316.e1-316.e11. PubMed ID: 36243664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.
    Chen F; Madduri RK; Rodriguez AA; Darst BF; Chou A; Sheng X; Wang A; Shen J; Saunders EJ; Rhie SK; Bensen JT; Ingles SA; Kittles RA; Strom SS; Rybicki BA; Nemesure B; Isaacs WB; Stanford JL; Zheng W; Sanderson M; John EM; Park JY; Xu J; Wang Y; Berndt SI; Huff CD; Yeboah ED; Tettey Y; Lachance J; Tang W; Rentsch CT; Cho K; Mcmahon BH; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Sellers TA; Yamoah K; Murphy AB; Crawford DC; Patel AV; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas CM; Stern MC; Kote-Jarai Z; Govindasami K; Cook MB; Chokkalingam AP; Hsing AW; Goodman PJ; Hoffmann TJ; Drake BF; Hu JJ; Keaton JM; Hellwege JN; Clark PE; Jalloh M; Gueye SM; Niang L; Ogunbiyi O; Idowu MO; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Diop H; Van Den Eeden SK; Blanchet P; Fowke JH; Casey G; Hennis AJ; Lubwama A; Thompson IM; Leach R; Easton DF; Preuss MH; Loos RJ; Gundell SM; Wan P; Mohler JL; Fontham ET; Smith GJ; Taylor JA; Srivastava S; Eeles RA; Carpten JD; Kibel AS; Multigner L; Parent MÉ; Menegaux F; Cancel-Tassin G; Klein EA; Andrews C; Rebbeck TR; Brureau L; Ambs S; Edwards TL; Watya S; Chanock SJ; Witte JS; Blot WJ; Michael Gaziano J; Justice AC; Conti DV; Haiman CA
    Eur Urol; 2023 Jul; 84(1):13-21. PubMed ID: 36872133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a prostate cancer polygenic risk score.
    Black MH; Li S; LaDuca H; Lo MT; Chen J; Hoiness R; Gutierrez S; Tippin-Davis B; Lu HM; Gielzak M; Wiley K; Shi Z; Wei J; Zheng SL; Helfand BT; Isaacs W; Xu J
    Prostate; 2020 Nov; 80(15):1314-1321. PubMed ID: 33258481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.
    Chen F; Darst BF; Madduri RK; Rodriguez AA; Sheng X; Rentsch CT; Andrews C; Tang W; Kibel AS; Plym A; Cho K; Jalloh M; Gueye SM; Niang L; Ogunbiyi OJ; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Adjei AA; Diop H; Lachance J; Rebbeck TR; Ambs S; Gaziano JM; Justice AC; Conti DV; Haiman CA
    Elife; 2022 Jul; 11():. PubMed ID: 35801699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of clinically significant prostate cancer using polygenic risk models in Asians.
    Song SH; Kim E; Woo E; Kwon E; Yoon S; Kim JK; Lee H; Oh JJ; Lee S; Hong SK; Byun SS
    Investig Clin Urol; 2022 Jan; 63(1):42-52. PubMed ID: 34983122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of polygenic risk scores for predicting breast and prostate cancer risk.
    Machiela MJ; Chen CY; Chen C; Chanock SJ; Hunter DJ; Kraft P
    Genet Epidemiol; 2011 Sep; 35(6):506-514. PubMed ID: 21618606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs.
    Zheng J; Liu F; Lin X; Wang X; Ding Q; Jiang H; Chen H; Lu D; Jin G; Hsing AW; Shao Q; Qi J; Ye Y; Wang Z; Gao X; Wang G; Chu LW; Ouyang J; Huang Y; Chen Y; Gao Y; Shi R; Wu Q; Wang M; Zhang Z; Hu Y; Sun J; Zheng SL; Gao X; Xu C; Mo Z; Sun Y; Xu J
    Prostate; 2012 Apr; 72(5):577-83. PubMed ID: 21796652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry.
    Pagadala MS; Linscott JA; Talwar JV; Seibert TM; Rose B; Lynch J; Panizzon M; Hauger R; Hansen MH; Sammon JD; Hayn MH; Kader K; Carter H; Ryan ST
    BMC Cancer; 2022 Dec; 22(1):1289. PubMed ID: 36494783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polygenic risk prediction models for colorectal cancer: a systematic review.
    Sassano M; Mariani M; Quaranta G; Pastorino R; Boccia S
    BMC Cancer; 2022 Jan; 22(1):65. PubMed ID: 35030997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating European GWAS findings improve polygenic risk prediction accuracy of breast cancer among East Asians.
    Ji Y; Long J; Kweon SS; Kang D; Kubo M; Park B; Shu XO; Zheng W; Tao R; Li B
    Genet Epidemiol; 2021 Jul; 45(5):471-484. PubMed ID: 33739539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.
    Amin Al Olama A; Benlloch S; Antoniou AC; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Muir K; Schleutker J; Henderson BE; Haiman CA; Schumacher FR; Pashayan N; Pharoah PD; Ostrander EA; Stanford JL; Batra J; Clements JA; Chambers SK; Weischer M; Nordestgaard BG; Ingles SA; Sorensen KD; Orntoft TF; Park JY; Cybulski C; Maier C; Doerk T; Dickinson JL; Cannon-Albright L; Brenner H; Rebbeck TR; Zeigler-Johnson C; Habuchi T; Thibodeau SN; Cooney KA; Chappuis PO; Hutter P; Kaneva RP; Foulkes WD; Zeegers MP; Lu YJ; Zhang HW; Stephenson R; Cox A; Southey MC; Spurdle AB; FitzGerald L; Leongamornlert D; Saunders E; Tymrakiewicz M; Guy M; Dadaev T; Little SJ; Govindasami K; Sawyer E; Wilkinson R; Herkommer K; Hopper JL; Lophatonanon A; Rinckleb AE; Kote-Jarai Z; Eeles RA; Easton DF; ; ;
    Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1121-9. PubMed ID: 25837820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy.
    Ruan X; Huang D; Huang J; Huang J; Zhan Y; Wu Y; Ding Q; Xu D; Jiang H; Xue W; Na R
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polygenic risk score in prostate cancer.
    Oh JJ; Hong SK
    Curr Opin Urol; 2022 Sep; 32(5):466-471. PubMed ID: 35855560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and optimization of a polygenic risk model for venous thromboembolism in the Chinese population.
    Liu C; Hou J; Li W; Chen J; Li Y; Zhang J; Zhou W; Zhang W; Deng F; Wang Y; Chen L; Qin S; Meng X; Lu S
    J Vasc Surg Venous Lymphat Disord; 2024 Jan; 12(1):101666. PubMed ID: 37619711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study.
    Cheng Y; Wu L; Xin J; Ben S; Chen S; Li H; Zhao L; Wang M; Cheng G; Du M
    J Transl Med; 2024 Apr; 22(1):366. PubMed ID: 38632662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes.
    Ruan X; Huang D; Huang J; Tsu JH; Na R
    J Transl Med; 2023 Jul; 21(1):446. PubMed ID: 37415201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk.
    Dite GS; Spaeth E; Murphy NM; Allman R
    Prostate; 2023 Jul; 83(10):962-969. PubMed ID: 37062910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma.
    Gu F; Chen TH; Pfeiffer RM; Fargnoli MC; Calista D; Ghiorzo P; Peris K; Puig S; Menin C; De Nicolo A; Rodolfo M; Pellegrini C; Pastorino L; Evangelou E; Zhang T; Hua X; DellaValle CT; Timothy Bishop D; MacGregor S; Iles MI; Law MH; Cust A; Brown KM; Stratigos AJ; Nagore E; Chanock S; Shi J; Consortium MM; Consortium M; Landi MT
    Hum Mol Genet; 2018 Dec; 27(23):4145-4156. PubMed ID: 30060076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.
    Barnett GC; Kerns SL; Dorling L; Fachal L; Aguado-Barrera ME; Martínez-Calvo L; Jandu HK; Welsh C; Tyrer J; Coles CE; Haviland JS; Parker C; Gómez-Caamaño A; Calvo-Crespo P; Sosa-Fajardo P; Burnet NG; Summersgill H; Webb A; De Ruysscher D; Seibold P; Chang-Claude J; Talbot CJ; Rattay T; Parliament M; De Ruyck K; Rosenstein BS; Pharoah PDP; Dunning AM; Vega A; West CML;
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):494-501. PubMed ID: 35840111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.